RecruitingNCT06776874

Observational Study to Develop a Predictive Score for Adverse Events Post ERCP

Studio Osservazionale Per lo Sviluppo di Uno Score Predittivo Degli Eventi Avversi Post-colangiopancreatografia Retrograda Endoscopica (ERCP)


Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

981 participants

Start Date

Mar 24, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The main objective of the study is: the identification of independent factors associated with an increased risk of post-ERCP complications. Other objectives are: the development of a predictive model of events post-ERCP adverse events and its validation; geographic validation of a predictive model already published in the literature using data collected during the study and the evaluation of the rate of post-ERCP AEs in the centers involved in the study.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Age \>18 years
  • Patients admitted with hepato-biliary-pancreatic disease or other pathological conditions that require treatment by ERCP
  • Obtaining informed consent

Exclusion Criteria1

  • None

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06776874


Related Trials